IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 16 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,239,102 | +0.3% | 1,314,000 | 0.0% | 0.00% | – |
| Q2 2023 | $1,235,975 | +2.0% | 1,314,000 | 0.0% | 0.00% | – |
| Q1 2023 | $1,211,889 | +1.5% | 1,314,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,193,861 | +0.5% | 1,314,000 | +0.5% | 0.00% | – |
| Q3 2022 | $1,188,000 | -10.1% | 1,308,000 | -13.3% | 0.00% | – |
| Q2 2022 | $1,322,000 | -7.0% | 1,508,000 | -4.6% | 0.00% | – |
| Q1 2022 | $1,421,000 | +174.3% | 1,580,000 | +172.4% | 0.00% | – |
| Q4 2021 | $518,000 | -84.9% | 580,000 | -84.6% | 0.00% | -100.0% |
| Q3 2021 | $3,437,000 | -31.0% | 3,769,000 | -29.7% | 0.00% | 0.0% |
| Q2 2021 | $4,981,000 | -19.3% | 5,359,000 | -17.1% | 0.00% | 0.0% |
| Q1 2021 | $6,169,000 | +136.2% | 6,461,000 | +152.5% | 0.00% | 0.0% |
| Q4 2020 | $2,612,000 | – | 2,559,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 36,587,000 | $34,026,000 | 3.65% |
| DeepCurrents Investment Group LLC | 77,144,000 | $71,504,000 | 2.14% |
| STEELHEAD PARTNERS LLC | 28,000,000 | $26,028,000 | 1.72% |
| Context Capital Management, LLC | 13,000 | $12,147,000 | 1.12% |
| CAMDEN ASSET MANAGEMENT L P /CA | 26,324,000 | $24,465,000 | 1.02% |
| Penn Mutual Asset Management, LLC | 856 | $790,000 | 0.99% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 41,774,000 | $38,742,000 | 0.84% |
| PFM Health Sciences, LP | 23,000,000 | $21,372,000 | 0.67% |
| AQR Arbitrage LLC | 19,050,000 | $17,800,000 | 0.50% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 19,910,000 | $18,377,000 | 0.36% |